Innate immunity and host defense peptides in veterinary medicine

Journal of Veterinary Internal Medicine

Volumn 22, Issue 2, 2008, Pages 247-265

  Linde, A ^a,c   Ross, C R ^a,c   Davis, E G ^a,c   Dib, L ^b,c   Blecha, F ^a,c   Melgarejo, T ^b,c  

^a Department of Anatomy and Physiology ^*

^b Department of Clinical Sciences ^*

^c KANSAS STATE UNIVERSITY   (United States)

Author keywords

Antimicrobial peptides; Danger associated molecular patterns; Natural antibiotics; Pathogen associated molecular patterns; Pattern recognition receptors; Toll like receptors

Indexed keywords

CATHELICIDIN; DEFENSIN;

ANIMAL; ANIMAL DISEASE; CHEMISTRY; DOMESTIC ANIMAL; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; METHODOLOGY; PHYSIOLOGY; REVIEW; VETERINARY MEDICINE;

ANIMAL DISEASES; ANIMALS; ANIMALS, DOMESTIC; CATHELICIDINS; DEFENSINS; IMMUNITY, NATURAL; VETERINARY MEDICINE;

ANIMALIA;

EID: 42449099431     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2007.0038.x     Document Type: Review

References (248)

1. Ganz T, Weiss J. Antimicrobial peptides of phagocytes and epithelia. Semin Hematol 1997;34:343-354.
2. Oppenheim JJ, Biragyn A, Kwak LW, et al. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis 2003;62(Suppl 2):ii17-ii21.
3. Sima P, Trebichavsky I, Sigler K. Mammalian antibiotic peptides. Folia Microbiol (Praha) 2003;48:123-137.
4. Ganz T, Lehrer RI. Defensins. Curr Opin Immunol 1994;6:584-589.
5. Zanetti M, Gennaro R, Romeo D. Cathelicidins: A novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 1995;374:1-5.
6. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.
7. Boman HG. Antibacterial peptides: Basic facts and emerging concepts. J Intern Med 2003;254:197-215.
8. Ganz T, Lehrer RI. Antibiotic peptides from higher eukaryotes: Biology and applications. Mol Med Today 1999;5:292-297.
9. Schonwetter BS, Stolzenberg ED, Zasloff MA. Epithelial antibiotics induced at sites of inflammation. Science 1995;267:1645-1648.
10. Brogden KA, Ackermann M, McCray PB Jr, et al. Antimicrobial peptides in animals and their role in host defences. Int J Antimicrob Agents 2003;22:465-478.
11. Ganz T. Defensins and other antimicrobial peptides: A historical perspective and an update. Comb Chem High Throughput Screen 2005;8:209-217.
12. Lee TD, Gonzalez ML, Kumar P, et al. CAP37, a novel inflammatory mediator: Its expression in endothelial cells and localization to atherosclerotic lesions. Am J Pathol 2002;160: 841-848.
13. Linde A, Mosier D, Blecha F, et al. Innate immunity and inflammation-New frontiers in comparative cardiovascular pathology. Cardiovasc Res 2007;73:26-36.
14. Matzinger P. Friendly and dangerous signals: Is the tissue in control? Nat Immunol 2007;8:11-13.
15. Scott MG, Hancock RE. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit Rev Immunol 2000;20:407-431.
16. Ganz T, Selsted ME, Lehrer RI. Defensins. Eur J Haematol 1990;44:1-8.
17. Yang D, Biragyn A, Kwak LW, et al. Mammalian defensins in immunity: More than just microbicidal. Trends Immunol 2002;23:291-296.
18. Yang D, Biragyn A, Hoover DM, et al. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol 2004;22:181-215.
19. Kougias P, Chai H, Lin PH, et al. Defensins and cathelicidins: Neutrophil peptides with roles in inflammation, hyperlipidemia and atherosclerosis. J Cell Mol Med 2005;9:3-10.
20. Nassar H, Lavi E, Akkawi S, et al. Alpha-defensin: Link between inflammation and atherosclerosis. Atherosclerosis 2006; 192(2):452-457.
21. Froy O, Hananel A, Chapnik N, et al. Differential effect of insulin treatment on decreased levels of beta-defensins and Toll-like receptors in diabetic rats. Mol Immunol 2007;44:796-802.
22. Bekri S, Gual P, Anty R, et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006;131:788-796.
23. Hancock RE, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 2006;24:1551-1557.
24. Ouellette AJ, Selsted ME. Paneth cell defensins: Endogenous peptide components of intestinal host defense. FASEB J 1996;10:1280-1289.
25. Wah J, Wellek A, Frankenberger M, et al. Antimicrobial peptides are present in immune and host defense cells of the human respiratory and gastroinstestinal tracts. Cell Tissue Res 2006;324:449-456.
26. Zasloff M. Antimicrobial peptides in health and disease. N Engl J Med 2002;347:1199-1200.
27. Selsted ME, Ouellette AJ. Mammalian defensins in the antimicrobial immune response. Nat Immunol 2005;6:551-557.
28. Nguyen TX, Cole AM, Lehrer RI. Evolution of primate theta-defensins: A serpentine path to a sweet tooth. Peptides 2003;24:1647-1654.
29. Selsted ME. Theta-defensins: Cyclic antimicrobial peptides produced by binary ligation of truncated alpha-defensins. Curr Protein Pept Sci 2004;5:365-371.
30. Tang YQ, Yuan J, Osapay G, et al. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science 1999;286:498-502.
31. Ganz T, Lehrer RI. Antimicrobial peptides of vertebrates. Curr Opin Immunol 1998;10:41-44.
32. Tomasinsig L, Zanetti M. The cathelicidins-Structure, function and evolution. Curr Protein Pept Sci 2005;6:23-34.
33. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 2004;75:39-48.
34. Wu H, Zhang G, Ross CR, et al. Cathelicidin gene expression in porcine tissues: Roles in ontogeny and tissue specificity. Infect Immun 1999;67:439-442.
35. Lee PH, Ohtake T, Zaiou M, et al. Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc Natl Acad Sci USA 2005;102:3750-3755.
36. Nagaoka I, Hirota S, Yomogida S, et al. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm Res 2000;49:73-79.
37. Diamond G, Russell JP, Revins CL. Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proc Natl Acad Sci USA 1996;93:5156-5160.
38. Russell JP, Diamond G, Tarver AP, et al. Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysaccharide and tumor necrosis factor alpha. Infect Immun 1996;64:1565-1568.
39. Diamond G, Kaiser V, Rhodes J, et al. Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells. Infect Immun 2000;68:113-119.
40. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1999;1462:55-70.
41. Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta 1999;1462:1-10.
42. Yang L, Weiss TM, Lehrer RI, et al. Crystallization of antimicrobial pores in membranes: Magainin and protegrin. Biophys J 2000;79:2002-2009.
43. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-395.
44. Steiner H, Andreu D, Merrifield RB. Binding and action of cecropin and cecropin analogues: Antibacterial peptides from insects. Biochim Biophys Acta 1988;939:260-266.
45. Xiong YQ, Yeaman MR, Bayer AS. In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action. Antimicrob Agents Chemother 1999;43:1111-1117.
46. Yoneyama M, Kikuchi M, Matsumoto K, et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005;175:2851-2858.
47. Robinson MJ, Sancho D, Slack EC, et al. Myeloid C-type lectins in innate immunity. Nat Immunol 2006;7:1258-1265.
48. Fritz JH, Ferrero RL, Philpott DJ, et al. Nod-like proteins in immunity, inflammation and disease. Nat Immunol 2006;7:1250-1257.
49. Seong SY, Matzinger P. Hydrophobicity: An ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004;4:469-478.
50. Dalpke AH, Lehner MD, Hartung T, et al. Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance. Immunology 2005;116:203-212.
51. Krisanaprakornkit S, Kimball JR, Dale BA. Regulation of human beta-defensin-2 in gingival epithelial cells: The involvement of mitogen-activated protein kinase pathways, but not the NF-kappaB transcription factor family. J Immunol 2002;168:316-324.
52. Scott AM, Saleh M. The inflammatory caspases: Guardians against infections and sepsis. Cell Death Differ 2007;14:23-31.
53. Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: Master switches of inflammation. Cell Death Differ 2007;14:10-22.
54. van WS, Mannesse-Lazeroms SP, Van Sterkenburg MA, et al. Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am J Physiol 1997;272(5 Pt 1):L888-L896.
55. Chertov O, Michiel DF, Xu L, et al. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem 1996;271:2935-2940.
56. Gallo RL, Ono M, Povsic T, et al. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci USA 1994;91:11035-11039.
57. van den Berg RH, Faber-Krol MC, van WS, et al. Inhibition of activation of the classical pathway of complement by human neutrophil defensins. Blood 1998;92:3898-3903.
58. Panyutich AV, Panyutich EA, Krapivin VA, et al. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J Lab Clin Med 1993;122:202-207.
59. Soong LB, Ganz T, Ellison A, et al. Purification and characterization of defensins from cystic fibrosis sputum. Inflamm Res 1997;46:98-102.
60. Bals R, Weiner DJ, Moscioni AD, et al. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun 1999;67:6084-6089.
61. Gennaro R, Zanetti M. Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers 2000;55:31-49.
62. Chertov O, Yang D, Howard OM, et al. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev 2000;177:68-78.
63. De Y, Chen Q, Schmidt AP, et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000;192:1069-1074.
64. Charp PA, Rice WG, Raynor RL, et al. Inhibition of protein kinase C by defensins, antibiotic peptides from human neutrophils. Biochem Pharmacol 1988;37:951-956.
65. Zhou CX, Zhang YL, Xiao L, et al. An epididymis-specific beta-defensin is important for the initiation of sperm maturation. Nat Cell Biol 2004;6:458-464.
66. Davis EG, Sang Y, Blecha F. Equine beta-defensin-1: Full-length cDNA sequence and tissue expression. Vet Immunol Immunopathol 2004;99:127-132.
67. Scocchi M, Bontempo D, Boscolo S, et al. Novel cathelicidins in horse leukocytes (1). FEBS Lett 1999;457:459-464.
68. Sang Y, Ortega MT, Blecha F, et al. Molecular cloning and characterization of three beta-defensins from canine testes. Infect Immun 2005;73:2611-2620.
69. Patil AA, Cai Y, Sang Y, et al. Cross-species analysis of the mammalian beta-defensin gene family: Presence of syntenic gene clusters and preferential expression in the male reproductive tract. Physiol Genomics 2005;23:5-17.
70. Sang Y, Teresa OM, Rune K, et al. Canine cathelicidin (K9CATH): Gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide. Dev Comp Immunol 2007;31(12):1278-1296.
71. Fry MM, Liggett JL, Baek SJ. Molecular cloning and expression of canine hepcidin. Vet Clin Pathol 2004;33:223-227.
72. Lin DS, Bowman DD, Jacobson RH. Immunological changes in cats with concurrent Toxoplasma gondii and feline immunodeficiency virus infections. J Clin Microbiol 1992;30:17-24.
73. Lappin MR, George JW, Pedersen NC, et al. Primary and secondary Toxoplasma gondii infection in normal and feline immunodeficiency virus-infected cats. J Parasitol 1996;82:733-742.
74. Ignacio G, Nordone S, Howard KE, et al. Toll-like receptor expression in feline lymphoid tissues. Vet Immunol Immunopathol 2005;106:229-237.
75. Wassef A, Janardhan K, Pearce JW, et al. Toll-like receptor 4 in normal and inflamed lungs and other organs of pig, dog and cattle. Histol Histopathol 2004;19:1201-1208.
76. Ishii M, Hashimoto M, Oguma K, et al. Molecular cloning and tissue expression of canine Toll-like receptor 2 (TLR2). Vet Immunol Immunopathol 2006;110:87-95.
77. Bazzocchi C, Mortarino M, Comazzi S, et al. Expression and function of Toll-like receptor 2 in canine blood phagocytes. Vet Immunol Immunopathol 2005;104:15-19.
78. Hashimoto M, Asahina Y, Sano J, et al. Cloning of canine toll-like receptor 9 and its expression in dog tissues. Vet Immunol Immunopathol 2005;106:159-163.
79. Linde A, Blecha F, Melgarejo T. Toll-like receptor (TLR) 2 and TLR4 gene expression in canine heart. Am J Anim Vet Sci 2007;2:6-10.
80. Swerdlow MP, Kennedy DR, Kennedy JS, et al. Expression and function of TLR2, TLR4, and Nod2 in primary canine colonic epithelial cells. Vet Immunol Immunopathol 2006;114:313-319.
81. Alberola J, Rodriguez A, Francino O, et al. Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis. Antimicrob Agents Chemother 2004;48:641-643.
82. Pellegrini A, Hageli G, von FR. Isolation and characterization of two new low-molecular-weight protein proteinase inhibitors from the granule-rich fraction of equine neutrophilic granulocytes. Biochim Biophys Acta 1988;952:309-316.
83. Couto MA, Harwig SS, Cullor JS, et al. eNAP-2, a novel cysteine-rich bactericidal peptide from equine leukocytes. Infect Immun 1992;60:5042-5047.
84. Couto MA, Harwig SS, Cullor JS, et al. Identification of eNAP-1, an antimicrobial peptide from equine neutrophils. Infect Immun 1992;60:3065-3071.
85. Skerlavaj B, Scocchi M, Gennaro R, et al. Structural and functional analysis of horse cathelicidin peptides. Antimicrob Agents Chemother 2001;45:715-722.
86. Davis EG, Sang Y, Rush B, et al. Molecular cloning and characterization of equine NK-lysin. Vet Immunol Immunopathol 2005;105:163-169.
87. Looft C, Paul S, Philipp U, et al. Sequence analysis of a 212 kb defensin gene cluster on ECA 27q17. Gene 2006;376:192-198.
88. Yasui T, Tsukise A, Fukui K, et al. Aspects of glycoconjugate production and lysozyme-and defensins-expression of the ceruminous glands of the horse (Equus przewalskii f.dom.). Eur J Morphol 2005;42:127-134.
89. Couto MA, Harwig SS, Lehrer RI. Selective inhibition of microbial serine proteases by eNAP-2, an antimicrobial peptide from equine neutrophils. Infect Immun 1993;61:2991-2994.
90. Savoini A, Marzari R, Dolzani L, et al. Wide-spectrum antibiotic activity of bovine granulocyte polypeptides. Antimicrob Agents Chemother 1984;26:405-407.
91. Tydell CC, Yount N, Tran D, et al. Isolation, characterization, and antimicrobial properties of bovine oligosaccharide-binding protein. A microbicidal granule protein of eosinophils and neutrophils. J Biol Chem 2002;277:19658-19664.
92. Selsted ME, Novotny MJ, Morris WL, et al. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J Biol Chem 1992;267:4292-4295.
93. Hsu CH, Chen C, Jou ML, et al. Structural and DMA-binding studies on the bovine antimicrobial peptide, indolicidin: Evidence for multiple conformations involved in binding to membranes and DNA. Nucleic Acids Res 2005;33:4053-4064.
94. Diamond G, Zasloff M, Eck H, et al. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: Peptide isolation and cloning of a cDNA. Proc Natl Acad Sci USA 1991;88:3952-3956.
95. Tarver AP, Clark DP, Diamond G, et al. Enteric beta-defensin: Molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection. Infect Immun 1998;66:1045-1056.
96. Aono S, Li C, Zhang G, et al. Molecular and functional characterization of bovine beta-defensin-1. Vet Immunol Immunopathol 2006;113:181-190.
97. Roosen S, Exner K, Paul S, et al. Bovine beta-defensins: Identification and characterization of novel bovine beta-defensin genes and their expression in mammary gland tissue. Mamm Genome 2004;15:834-842.
98. Yount NY, Yuan J, Tarver A, et al. Cloning and expression of bovine neutrophil beta-defensins. Biosynthetic profile during neutrophilic maturation and localization of mature peptide to novel cytoplasmic dense granules. J Biol Chem 1999;274:26249-26258.
99. Selsted ME, Tang YQ, Morris WL, et al. Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils. J Biol Chem 1993;268:6641-6648.
100. Ryan LK, Rhodes J, Bhat M, et al. Expression of beta-defensin genes in bovine alveolar macrophages. Infect Immun 1998;66:878-881.
101. Stolzenberg ED, Anderson GM, Ackermann MR, et al. Epithelial antibiotic induced in states of disease. Proc Natl Acad Sci USA 1997;94:8686-8690.
102. Diamond G, Jones DE, Bevins CL. Airway epithelial cells are the site of expression of a mammalian antimicrobial peptide gene. Proc Natl Acad Sci USA 1993;90:4596-4600.
103. Caverly JM, Diamond G, Gallup JM, et al. Coordinated expression of tracheal antimicrobial peptide and inflammatory-response elements in the lungs of neonatal calves with acute bacterial pneumonia. Infect Immun 2003;71:2950-2955.
104. Lawyer C, Watabe M, Pai S, et al. A synthetic form of tracheal antimicrobial peptide has both bactericidal and antifungal activities. Drug Des Discov 1996;14:171-178.
105. Swanson K, Gorodetsky S, Good L, et al. Expression of a beta-defensin mRNA, lingual antimicrobial peptide, in bovine mammary epithelial tissue is induced by mastitis. Infect Immun 2004;72:7311-7314.
106. Goldammer T, Zerbe H, Molenaar A, et al. Mastitis increases mammary mRNA abundance of beta-defensin 5, Toll-like-receptor 2 (TLR2), and TLR4 but not TLR9 in cattle. Clin Diagn Lab Immunol 2004;11:174-185.
107. Yang W, Molenaar A, Kurts-Ebert B, et al. NF-kappaB factors are essential, but not the switch, for pathogen-related induction of the bovine beta-defensin 5-encoding gene in mammary epithelial cells. Mol Immunol 2006;43:210-225.
108. Mitchell GB, Al-Haddawi MH, Clark ME, et al. Effect of corticosteroids and neuropeptides on the expression of defensins in bovine tracheal epithelial cells. Infect Immun 2006; 75:1325-1334.
109. Gennaro R, Skerlavaj B, Romeo D. Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils. Infect Immun 1989;57:3142-3146.
110. Zanetti M, Litteri L, Gennaro R, et al. Bactenecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in the large granules. J Cell Biol 1990;111:1363-1371.
111. Frank RW, Gennaro R, Schneider K, et al. Amino acid sequences of two proline-rich bactenecins. Antimicrobial peptides of bovine neutrophils. J Biol Chem 1990;265:18871-18874.
112. Scocchi M, Romeo D, Zanetti M. Molecular cloning of Bac7, a proline- and arginine-rich antimicrobial peptide from bovine neutrophils. FEBS Lett 1994;352:197-200.
113. Scocchi M, Romeo D, Cinco M. Antimicrobial activity of two bactenecins against spirochetes. Infect Immun 1993;61:3081-3083.
114. Wu M, Hancock RE. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J Biol Chem 1999;274:29-35.
115. Tomasinsig L, Scocchi M, Di LC, et al. Inducible expression of an antimicrobial peptide of the innate immunity in polymorphonuclear leukocytes. J Leukoc Biol 2002;72:1003-1010.
116. Skerlavaj B, Gennaro R, Bagella L, et al. Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J Biol Chem 1996;271:28375-28381.
117. Gennaro R, Scocchi M, Merluzzi L, et al. Biological characterization of a novel mammalian antimicrobial peptide. Biochim Biophys Acta 1998;1425:361-368.
118. Scocchi M, Wang S, Zanetti M. Structural organization of the bovine cathelicidin gene family and identification of a novel member. FEES Lett 1997;417:311-315.
119. Risso A, Braidot E, Sordano MC, et al. BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore. Mol Cell Biol 2002;22:1926-1935.
120. Ghiselli R, Giacometti A, Cirioni O, et al. Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide. Shock 2003;19:577-581.
121. Mookherjee N, Wilson HL, Doria S, et al. Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide. J Leukoc Biol 2006;80:1563-1574.
122. Brogden KA, Nordholm G, Ackermann M. Antimicrobial activity of cathelicidins BMAP28, SMAP28, SMAP29, and PMAP23 against Pasteurella multocida is more broad-spectrum than host species specific. Vet Microbiol 2007;119:76-81.
123. Bowdish DM, Davidson DJ, Scott MG, et al, Immunomodulatory activities of small host defense peptides. Antimicrob Agents Chemother 2005;49:1727-1732.
124. Lee DG, Kim HK, Kim SA, et al. Fungicidal effect of indolicidin and its interaction with phospholipid membranes. Biochem Biophys Res Commun 2003;305:305-310.
125. Falla TJ, Hancock RE. Improved activity of a synthetic indolicidin analog. Antimicrob Agents Chemother 1997;41:771-775.
126. Subbalakshmi C, Sitaram N. Mechanism of antimicrobial action of indolicidin. FEMS Microbiol Lett 1998;160:91-96.
127. Ryge TS, Doisy X, Ifrah D, et al. New indolicidin analogues with potent antibacterial activity. J Pept Res 2004;64:171-185.
128. Clare DA, Swaisgood HE. Bioactive milk peptides: A prospectus. J Dairy Sci 2000;83:1187-1195.
129. Kilara A, Panyam D. Peptides from milk proteins and their properties. Crit Rev Food Sci Nutr 2003;43:607-633.
130. Vorland LH. Lactoferrin: A multifunctional glycoprotein. APMIS 1999;107:971-981.
131. Tomita M, Takase M, Bellamy W, et al. A review: The active peptide of lactoferrin. Acta Paediatr Jpn 1994;36:585-591.
132. Tomita M, Takase M, Wakabayashi H, et al. Antimicrobial peptides of lactoferrin. Adv Exp Med Biol 1994;357:209-218.
133. Yamauchi K, Tomita M, Giehl TJ, et al. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 1993;61:719-728.
134. Haukland HH, Vorland LH. Post-antibiotic effect of the antimicrobial peptide lactoferricin on Escherichia coli and Staphylococcus aureus. J Antimicrob Chemother 2001;48:569-571.
135. Bellamy W, Wakabayashi H, Takase M, et al. Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med Microbiol Immunol (Berlin) 1993;182:97-105.
136. Vorland LH, Ulvatne H, Andersen J, et al. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. Scand J Infect Dis 1998;30:513-517.
137. Jones EM, Smart A, Bloomberg G, et al. Lactoferricin, a new antimicrobial peptide. J Appl Bacteriol 1994;77:208-214.
138. Di Biase AM, Tinari A, Pietrantoni A, et al. Effect of bovine lactoferricin on enteropathogenic Yersinia adhesion and invasion in HEp-2 cells. J Med Microbiol 2004;53(Pt 5):407-412.
139. van der Strate BW, Beljaars L, Molema G, et al. Antiviral activities of lactoferrin. Antiviral Res 2001;52:225-239.
140. Pietrantoni A, Di Biase AM, Tinari A, et al. Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides. Antimicrob Agents Chemother 2003; 47:2688-2691.
141. Chen PW, Shyu CL, Mao FC. Antibacterial activity of short Hydrophobie and basic-rich peptides. Am J Vet Res 2003;64:1088-1092.
142. Meisel H Biochemical properties of peptides encrypted in bovine milk proteins. Curr Med Chem 2005;12:1905-1919.
143. Tomita M, Wakabayashi H, Yamauchi K, et al. Bovine lactoferrin and lactoferricin derived from milk: Production and applications. Biochem Cell Biol 2002;80:109-112.
144. Fales-Williams AJ, Brogden KA, Huffman E, et al. Cellular distribution of anionic antimicrobial peplide in normal lung and during acute pulmonary inflammation. Vet Pathol 2002; 39:706-711.
145. Huttner KM, Brezinski-Caliguri DJ, Mahoney MM, et al. Antimicrobial peptide expression is developmentally regulated in the ovine gastrointestinal tract. J Nutr 1998;128(2 Suppl):297S-299S.
146. Ackermann MR, Gallup JM, Zabner J, et al. Differential expression of sheep beta-defensin-1 and -2 and interleukin 8 during acute Mannheimia haemolytica pneumonia. Microb Pathog 2004;37:21-27.
147. Zhao C, Nguyen T, Liu L, et al. Differential expression of caprine beta-defensins in digestive and respiratory tissues. Infect Immun 1999;67:6221-6224.
148. Kimura M, Nam MS, Ohkouchi Y, et al. Antimicrobial peptide of Korean native goat lactoferrin and identification of the part essential for this activity. Biochem Biophys Res Commun 2000;268:333-336.
149. Shamova O, Brogden KA, Zhao C, et al. Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes. Infect Immun 1999;67:4106-4111.
150. Huttner KM, Lambeth MR, Burkin HR, et al. Localization and genomic organization of sheep antimicrobial peptide genes. Gene 1998;206:85-91.
151. Anderson RC, Yu PL. Isolation and characterisation of proline/arginine-rich cathelicidin peptides from ovine neutrophils. Biochem Biophys Res Commun 2003;312:1139-1146.
152. Bagella L, Scocchi M, Zanetti M. cDNA sequences of three sheep myeloid cathelicidins. FEBS Lett 1995;376:225-228.
153. Travis SM, Anderson NN, Forsyth WR, et al. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun 2000;68:2748-2755.
154. Anderson RC, Hancock RE, Yu PL. Antimicrobial activity and bacterial-membrane interaction of ovine-derived cathelicidins. Antimicrob Agents Chemother 2004;48:673-676.
155. Skerlavaj B, Benincasa M, Risso A, et al. SMAP-29: A potent antibacterial and antifungal peptide from sheep leukocytes. FEBS Lett 1999;463:58-62.
156. Lee DG, Kim PI, Park Y, et al. Antifungal mechanism of SMAP-29 (1-18) isolated from sheep myeloid mRNA against Trichosporon beigelii. Biochem Biophys Res Commun 2002; 295:591-596.
157. Tack BF, Sawai MV, Kearney WR, et al. SMAP-29 has two LPS-binding sites and a central hinge. Eur J Biochem 2002;269:1181-1189.
158. Brogden KA, Kalfa VC, Ackermann MR, et al. The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection. Antimicrob Agents Chemother 2001;45:331-334.
159. Kalfa VC, Jia HP, Kunkle RA, et al. Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells. Antimicrob Agents Chemother 2001;45:3256-3261.
160. Zhang G, Ross CR, Blecha F. Porcine antimicrobial peptides: New prospects for ancient molecules of host defense. Vet Res 2000;31:277-296.
161. Oswald IP. Role of intestinal epithelial cells in the innate immune defence of the pig intestine. Vet Res 2006;37:359-368.
162. Zhang G, Wu H, Shi J, et al. Molecular cloning and tissue expression of porcine beta-defensin-1. FEBS Lett 1998;424:37-40.
163. Veldhuizen EJ, Hendriks HG, Hogenkamp A, et al. Differential regulation of porcine beta-defensins 1 and 2 upon Salmonella infection in the intestinal epithelial cell line IPI-21. Vet Immunol lmmunopathol 2006;114:94-102.
164. Lee JY, Boman A, Sun CX, et al. Antibacterial peptides from pig intestine: Isolation of a mammalian cecropin. Proc Natl Acad Sci USA 1989;86:9159-9162.
165. Andersson M, Gunne H, Agerberth B, et al. NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin. 2, antibacterial and antitumour activity. EMBO J 1995;14: 1615-1625.
166. Chen HL, Yen CC, Lu CY, et al. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphyhcoccus aureus, and Candida albicans. J Agric Food Chem 2006;54:3277-3282.
167. Sang Y, Ramanathan B, Minton JE, et al. Porcine liver-expressed antimicrobial peptides, hepcidin and LEAP-2: Cloning and induction by bacterial infection. Dev Comp Immunol 2006;30:357-366.
168. Agerberth B, Lee JY, Bergman T, et al. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginme-rich antibacterial peptides. Eur J Biochem 1991;202:849-854.
169. Storici P, Zanetti M. A novel cDNA sequence encoding a pig leukocyte antimicrobial peptide with a cathelin-like prosequence. Biochem Biophys Res Commun 1993;196:1363-1368.
170. Shi J, Ross CR, Chengappa MM, et al. Identification of a proline-arginine-rich antibacterial peptide from neutrophils that is analogous to PR-39, an antibacterial peptide from the small intestine. J Leukoc Biol 1994;56:807-811.
171. Shi J, Ross CR, Leto TL, et al. PR-39, a proline-rich anti-bacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox. Proc Natl Acad Sci USA 1996:93:6014-6018.
172. Huang HJ, Ross CR, Blecha F. Chemoattractant properties of PR-39, a neutrophil antibacterial peptide. J Leukoc Biol 1997;61:624-029.
173. Ramanathan B, Wu H, Ross CR, et al. PR-39, a porcine antimicrobial peptide, inhibits apoptosis: Involvement of caspase-3. Dev Comp Immunol 2004;28:163-169.
174. Zhang G, Ross CR, Dritz SS, et al. Salmonella infection increases porcine antibacterial peptide concentrations in serum. Clin Diagn Lab Immunol 1997;4:774-777.
175. Wu H, Zhang G, Minton JE, et al. Regulation of cathelicidin gene expression: Induction by lipopolysaccharide, interleukin-6, retinoic acid, and Salmonella enterica serovar Typhimurium infection. Infect Immun 2000;68:5552-5558.
176. Boman HG, Agerberth B, Boman A. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun 1993; 61:2978-2984.
177. Gudmundsson GH, Magnusson KP, Chowdhary BP, et al. Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: Comparative mapping of the locus for the human peptide antibiotic FALL-39. Proc Natl Acad Sci USA 1995;92:7085-7089.
178. Shi J, Ross CR, Chengappa MM, et al. Antibacterial activity of a synthetic peptide (PR-26) derived from PR-39, a proline-arginine-rich neutrophil antimicrobial peptide. Antimicrob Agents Chemother 1996;40:115-121.
179. Hennig-Pauka I, Jacobsen I, Blecha F, et al. Differential proteomic analysis reveals increased cathelicidin expression in porcine bronchoalveolar lavage fluid after an Actinobacillus pleuropneumoniae infection. Vet Res 2006;37:75-87.
180. Kokryakov VN, Harwig SS, Panyutich EA, et al. Protegrins: Leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett 1993;327:231-236.
181. Steinberg DA, Hurst MA, Fujii CA, et al. Protegrin-1: A broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother 1997;41:1738-1742.
182. Storici P, Zanetti M. A cDNA derived from pig bone marrow cells predicts a sequence identical to the intestinal antibacterial peptide PR-39. Biochem Biophys Res Commun 1993;196:1058-1065.
183. Zhao C, Liu L, Lehrer RI. Identification of a new member of the protegrin family by cDNA cloning. FEBS Lett 1994;346:285-288.
184. Zhao C, Ganz T, Lehrer RI. The structure of porcine protegrin genes. FEBS Lett 1995;368:197-202.
185. Shi J, Ganz T. The role of protegrins and other elastase-activated polypeptides in the bactericidal properties of porcine inflammatory fluids. Infect Immun 1998;66:3611-3617.
186. Panyutich A, Shi J, Boutz PL, et al. Porcine polymorpho-nuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins. Infect Immun 1997;65:978-985.
187. Aumelas A, Mangoni M, Roumestand C, et al. Synthesis and solution structure of the antimicrobial peptide protegrin-1. Eur J Biochem 1996;237:575-583.
188. Sambri V, Marangoni A, Giacani L, et al. Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum. J Antimicrob Chemother 2002;50:895-902.
189. Yasin B, Harwig SS, Lehrer RI, et al. Susceptibility of Chlamydia trachomatis to protegrins and defensins. Infect Immun 1996;64:709-713.
190. Qu XD, Harwig SS, Oren AM, et al. Susceptibility of Neisseria gonorrhoeas to protegrins. Infect Immun 1996;64:1240-1245.
191. Fortney K, Totten PA, Lehrer RI, et al. Haemophilus ducreyi is susceptible to protegrin. Antimicrob Agents Chemother 1998;42:2690-2693.
192. Tamamura H, Murakami T, Horiuchi S, et al. Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus
193. Miyasaki KT, Iofel R, Oren A, et al. Killing of Fusobacterium nucleatum, Porphyromonas gingivalis and Prevotella intermedia by protegrins. J Periodontal Res 1998;33:91-98.
194. Miyasaki KT, Iofel R, Lehrer RI. Sensitivity of periodontal pathogens to the bactericidal activity of synthetic protegrins, antibiotic peptides derived from porcine leukocytes. J Dent Res 1997;76:1453-1459.
195. Miyakawa Y, Ratnakar P, Rao AG, et al. In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect Immun 1996;64:926-932.
196. Ceccarelli AV, Cole AM, Park AK, et al. Therapeutic effect of a pig-derived peptide antibiotic on porcine wound infections. Comp Med 2001;51:75-79.
197. Harwig SS, Kokryakov VN, Swiderek KM, et al. Prophenin-1, an exceptionally proline-rich antimicrobial peptide from porcine leukocytes. FEES Lett 1995;362:65-69.
198. Zhao C, Ganz T, Lehrer RI. Structures of genes for two cathelin-associated antimicrobial peptides: Prophenin-2 and PR-39. FEBS Lett 1995;376:130-134.
199. Zanetti M, Storici P, Tossi A, et al. Molecular cloning and chemical synthesis of a novel antibacterial peptide derived from pig myeloid cells. J Biol Chem 1994;269:7855-7858.
200. Storici P, Scocchi M, Tossi A, et al. Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid cDNA. FEBS Lett 1994;337:303-307.
201. Tossi A, Scocchi M, Zanetti M, et al. PMAP-37, a novel antibacterial peptide from pig myeloid cells. cDNA cloning, chemical synthesis and activity. Eur J Biochem 1995;228:941-946.
202. Scocchi M, Zelezetsky I, Benincasa M, et al. Structural aspects and biological properties of the cathelicidin PMAP-36. FEBS J 2005;272:4398-4406.
203. Lee DG, Kim DH, Park Y, et al. Fungicidal effect of antimicrobial peptide, PMAP-23, isolated from porcine myeloid against Candida albicans. Biochem Biophys Res Commun 2001;282:570-574.
204. Park Y, Jang SH, Lee DG, et al. Antinematodal effect of antimicrobial peptide, PMAP-23, isolated from porcine myeloid against Caenorhabditis elegans. J Pept Sci 2004;10:304-311.
205. Lee DG, Kim PI, Park Y, et al. Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid. Biochem Biophys Res Commun 2002;293:231-238.
206. Shi J, Zhang G, Wu H, et al. Porcine epithelial beta-defensin 1 is expressed in the dorsal tongue at antimicrobial concentrations. Infect Immun 1999;67:3121-3127.
207. Elahi S, Buchanan RM, Attah-Poku S, et al. The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets. Infect Immun 2006;74:2338-2352.
208. Sang Y, Ramanathan B, Ross CR, et al. Gene silencing and overexpression of porcine peptidoglycan recognition protein long isoforms: Involvement in beta-defensin-1 expression. Infect Immun 2005;73:7133-7141.
209. Sang Y, Patil AA, Zhang G, et al. Bioinformatic and expression analysis of novel porcine beta-defensins. Mamm Genome 2006;17:332-339.
210. Veldhuizen EJ, van Dijk A, Tersteeg MH, et al. Expression of beta-defensins pBD-1 and pBD-2 along the small intestinal tract of the pig: Lack of upregulation in vivo upon Salmonella typhimurium infection. Mol Immunol 2007;44:276-283.
211. Rutherfurd-Markwick KJ, Moughan PJ. Bioactive peptides derived from food. J AOAC Int 2005;88:955-966.
212. Hancock RE, Lehrer R. Cationic peptides: A new source of antibiotics. Trends Biotechnol 1998;16:82-88.
213. Evans EW, Beach GG, Wunderlich J, et al. Isolation of antimicrobial peptides from avian heterophils. J Leukoc Biol 1994;56:661-665.
214. Harwig SS, Swiderek KM, Kokryakov VN, et al. Gallinacins: Cysteine-rich antimicrobial peptides of chicken leukocytes. FEBS Lett 1994;342:281-285.
215. Evans EW, Beach FG, Moore KM, et al. Antimicrobial activity of chicken and turkey heterophil peptides CHP1, CHP2, THP1, and THP3. Vet Microbiol 1995;47:295-303.
216. Brockus CW, Jackwood MW, Harmon BG. Characterization of beta-defensin prepropeptide mRNA from chicken and turkey bone marrow. Anim Genet 1998;29:283-289.
217. Xiao Y, Hughes AL, Ando J, et al. A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: Implications for the origin and evolution of mammalian defensins. BMC Genomics 2004;5:56.
218. Xiao Y, Cai Y, Bommineni YR, et al. Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity. J Biol Chem 2006;281:2858-2867.
219. Kogut MH, Iqbal M, He H, et al. Expression and function of Toll-like receptors in chicken heterophils. Dev Comp Immunol 2005;29:791-807.
220. Zhao C, Nguyen T, Liu L, et al. Gallinacin-3, an inducible epithelial beta-defensin in the chicken. Infect Immun 2001;69:2684-2691.
221. Xiao Y, Dai H, Bommineni YR, et al. Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken. FEBS J 2006;273:2581-2593.
222. van Dijk A, Veldhuizen EJ, van Asten AJ, et al. CMAP27, a novel chicken cathelicidin-like antimicrobial protein. Vet Immunol Immunopathol 2005;106:321-327.
223. Townes CL, Michailidis G, Nile CJ, et al. Induction of cationic chicken liver-expressed antimicrobial peptide 2 in response to Salmonella enterica infection. Infect Immun 2004;72:6987-6993.
224. Lynn DJ, Higgs R, Gaines S, et al. Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken. Immunogenetics 2004;56:170-177.
225. Sugiarto H, Yu PL. Avian antimicrobial peptides: The defense role of beta-defensins. Biochem Biophys Res Commun 2004;323:721-727.
226. Thouzeau C, Le Maho Y, Froget G, et al. Spheniscins, avian beta-defensins in preserved stomach contents of the king penguin, Aptenodytes patagonicus. J Biol Chem 2003;278:51053-51058.
227. Joseph SW, Hayes JR, English LL, et al. Implications of multiple antimicrobial-resistant enterococci associated with the poultry environment. Food Addit Contam 2001;18:1118-1123.
228. Boman HG. Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 1995;13:61-92.
229. Scott MG, Gold MR, Hancock RE. Interaction of cationic peptides with lipoteichoic acid and Gram-positive bacteria. Infect Immun 1999;67:6445-6453.
230. Scott MG, Yan H, Hancock RE. Biological properties of structurally related alpha-helical cationic antimicrobial peptides. Infect Immun 1999;67:2005-2009.
231. Raz E. Organ-specific regulation of innate immunity. Nat Immunol 2007;8:3-4.
232. Birchler T, Seibl R, Buchner K, et al. Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein. Eur J Immunol 2001;31:3131-3137.
233. Fehlbaum P, Rao M, Zasloff M, et al. An essential amino acid induces epithelial beta -defensin expression. Proc Natl Acad Sci USA 2000;97:12723-12728.
234. Sansonetti PJ. The innate signaling of dangers and the dangers of innate signaling. Nat Immunol 2006;7:1237-1242.
235. Ma XT, Xu B, An LL, et al. Vaccine with beta-defensin 2-transduced leukemic cells activates innate and adaptive immunity to elicit potent antileukemia responses. Cancer Res 2006;66:1169-1176.
236. Harris RH, Wilk D, Bevins CL, et al. Identification and characterization of a mucosal antimicrobial peptide expressed by the chinchilla (Chinchilla lanigera) airway. J Biol Chem 2004;279:20250-20256.
237. Selsted ME, Harwig SS. Purification, primary structure, and antimicrobial activities of a guinea pig neutrophil defensin. Infect Immun 1987;55:2281-2286,
238. Befus AD, Mowat C, Gilchrist M, et al. Neutrophil defensins induce histamine secretion from mast cells: Mechanisms of action. J Immunol 1999;163:947-953.
239. Nagaoka I, Tsutsumi-Ishii Y, Yomogida S, et al. Isolation of cDNA encoding guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and evaluation of CAP11 mRNA expression during neutrophil maturation. J Biol Chem 1997;272:22742-22750.
240. Mak P, Wojcik K, Thogersen IB, et al. Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins. Infect Immun 1996;64:4444-4449.
241. Zaballos A, Villares R, Albar JP, et al. Identification on mouse chromosome 8 of new beta-defensin genes with regionally specific expression in the male reproductive organ. J Biol Chem 2004;279:12421-12426.
242. Gallo RL, Kim KJ, Bernfield M, et al. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem 1997;272:13088-13093.
243. Selsted ME, Brown DM, DeLange RJ, et al. Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem 1985;260:4579-4584.
244. Zarember KA, Katz SS, Tack BF, et al. Host defense functions of proteolytically processed and parent (unprocessed) cathelicidins of rabbit granulocytes. Infect Immun 2002;70:569-576.
245. Com E, Bourgeon F, Evrard B, et al. Expression of antimicrobial defensins in the male reproductive tract of rats, mice, and humans. Biol Reprod 2003;68:95-104.
246. Page RA, Malik AN. Elevated levels of beta defensin-1 mRNA in diabetic kidneys of GK rats. Biochem Biophys Res Commun 2003;310:513-521.
247. Termen S, Tollin M, Olsson B, et al. Phylogeny, processing and expression of the rat cathelicidin rCRAMP: A model for innate antimicrobial peptides. Cell Mol Life Sci 2003;60:536-549.
248. Risso A. Leukocyte antimicrobial peptides: Multifunctional effector molecules of innate immunity. J Leukoc Biol 2000;68:785-792.